** ReNerve RNV.AX swells 98.8% to a record high of A$0.220; last up 40.9%
** Stock set for biggest ever intraday pct gain
** Medical devices maker says patients using its NervAlign® Nerve Cuff, which aids regeneration of peripheral nerves after surgery or injury, reported significantly lower post-surgery pain
** RNV set to end the quarter 11.4% lower
** About 4.5 mln shares traded in stock's busiest session ever
** RNV loses 5.7% YTD
(Reporting by Manasi Dasa Sundeep in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。